drugset / Trial / NCT03159559

PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes

NCT03159559

Phase 4 Unknown 60 enrolled Tongji Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is undertaken to determine if intravenous Lipo-PGE1 therapy would improve coronary microvascular perfusion in patients with ischemic heart disease by CMRI.

Timeline

Start
2017-01
Primary completion
2017-12
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Alprostadil Unknown 10 ug Intravenous